Ausgabe 1/2025
Inhalt (19 Artikel)
Vebreltinib: a promising milestone in targeted therapy for METex14-mutant NSCLC
- Open Access
- Correspondence
LinRui Ma, WeiKang Meng, WenJuan Jiang
Comprehensive study of gene fusions in sarcomas
- Research
Nan Chen, Qin Zhang, Lei Sun, Xia You, Siqi Chen, Dongsheng Chen, Fengkun Yang
Efficacy and safety of the combination of envafolimab and lenvatinib in unresectable hepatocellular carcinoma: a single-arm, multicentre, exploratory phase II clinical study
- Open Access
- Research
Yi Jiang, Ke Su, Han Li, Chenjie Wang, Zhenying Wu, Jiali Chen, Zhiyao Zhang, Kun He, Yunwei Han
5-Fluorouracil-methotrexate conjugate enhances the efficacy of 5-fluorouracil in colorectal cancer therapy
- Research
Siyuan Zhao, Tiansi Wang, Kourong Shi, Ting Li, Qiuzhen Zhu, Yuan Li, Beiwei Xin, Xin Wu, Wei Fan
Clinical features, treatment, and outcomes of nivolumab induced psoriasis
- Research
Shaoli Zhao, Wei Sun, Jichun Sun, Liping Peng, Chunjiang Wang
Deficiency of myeloid discoidin domain receptor 2 aggravates melanoma lung and bone metastasis
- Research
Yue Sun, Liangliang Wei, Hao Liu, Gaoyang Zong, Zhihao Xia, Xiangyang Li, Zhanhai Yin, Dageng Huang, Yan Zhang
A Phase 1b study of the OxPhos inhibitor ME-344 with bevacizumab in refractory metastatic colorectal cancer
- Open Access
- Research
Patrick M. Boland, Heinz-Josef Lenz, Kristen K. Ciombor, Vaia Florou, Michael J. Pishvaian, Michael Cusnir, Deirdre Cohen, Jessie Y. Guo, Min Tang, Prabhu Rajagopalan, Sandra E. Wiley, Richard G. Ghalie, Howard S. Hochster
Immunotherapy in thymic epithelial tumors: an attractive dilemma
- Research
Nahed Damaj, Dany Nassar, Bilal Chamaa, Joseph Kattan
Clinical features, treatment, and prognosis of pembrolizumab -induced Stevens-Johnson syndrome / toxic epidermal necrolysis
- Research
Zhaoquan Wu, Xiting Li, Rui Huang, Binsheng He, Chunjiang Wang
Efficacy and safety of multi-target tyrosine kinase inhibitor AL2846 combined with gemcitabine in pancreatic cancer
- Research
Rui Liu, Zhi Ji, Xia Wang, Jiaqi Xin, Lila Zhu, Shaohua Ge, Le Zhang, Ming Bai, Tao Ning, Yuchong Yang, Hongli Li, Ting Deng, Yi Ba
Lenvatinib plus immunotherapy versus lenvatinib monotherapy in lenvatinib-insensitive patients with unresectable hepatocellular carcinoma: a retrospective study
- Open Access
- Research
Zeyu Yu, Bin Leng, Ran You, Chendong Wang, Lingfeng Diao, Qingyu Xu, Guowen Yin
Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA
- Research
Yoshihiko Taniguchi, Akihiro Tamiya, Mitsuo Osuga, Shun-ichi Isa, Keiichi Nakamura, Yasuyuki Mizumori, Tsutomu Shinohara, Hidetoshi Yanai, Katsumi Nakatomi, Masahide Oki, Masahide Mori, Tomohito Kuwako, Koji Yamazaki, Masahiro Shimada, Masahiko Ando, Yasuhiro Koh
The analysis of molecular classification of pulmonary neuroendocrine tumors and relationship between YAP1 and efficacy
- Research
Meihui Li, Xinyuan Wang, Jiali Gong, Hongyang Lu
Investigation of the association between therapeutic effectiveness of anamorelin and Glasgow prognostic score in patients with cancer cachexia: a competing risk analysis
- Research
Kazuhiro Shimomura, Takatsugu Ogata, Akimitsu Maeda, Yukiya Narita, Hiroya Taniguchi, Kenta Murotani, Yutaka Fujiwara, Masahiro Tajika, Kazuo Hara, Kei Muro, Kosaku Uchida
Dual PTCH2 mutation [Ser391*, Leu104Pro]: unveiling a potential new genetic susceptibility factor for glioma development
- Research
Xiang Li, Yingting Wu, Tiantian Han, Ran Ding, Rongrong Kong, Siqi Chen, Ningning Luo, Mingji Jin, Dongsheng Chen, Ping Zhang
Linifanib alone and in combination with metronomic chemotherapy is active on cutaneous T-cell lymphoma cells by targeting the AKT/mTOR signaling pathway
- Research
Marta Banchi, Maria Christina Cox, Arianna Bandini, Paola Orlandi, Costanza Tacchi, Fabio Stefanelli, Silvio Chericoni, Guido Bocci
Efficacy of ramucirumab combined with erlotinib or osimertinib in untreated EGFR-mutated NSCLC patients with asymptomatic brain metastases: insights from molecular biomarkers in the RELAY-brain trial
- Research
Hiroyasu Kaneda, Haruko Daga, Asuka Okada, Yuki Nakatani, Yoko Tani, Takako Oka, Kenji Sawa, Kazuko Sakai, Kazuto Nishio, Tomoya Kawaguchi
Synergistic antitumor effect of MK-1775 and CUDC-907 against prostate cancer
- Research
Saisai Ma, Yichen Xu, Minmin Liu, Shuaida Wu, Ye Zhang, Hongyan Xia, Ji Lu, Yang Zhan
Targeting MYC for the treatment of breast cancer: use of the novel MYC-GSPT1 degrader, GT19630
- Open Access
- Research
Minhong Tang, John Crown, Michael J. Duffy
